Skip to content
S

Sarah Abere

Publications (4)

Prevalence and Determinants of Hepatic Fibrosis and Steatosis as Measured by Fibroscan in an Unselected Population in Southern Nigeria

Sarah Abere, Boma Oyan, Linda Iroegbu-Emeruem & Ibinabo Membere · Journal of Advances in Medicine and Medical Research · 2025

Background: Fibroscan is a non-invasive medical device that uses proprietary vibration-controlled transient elastography to assess liver fibrosis and cirrhosis by measuring the degree of liver stiffness. Fibroscan remain a reliable tool for the diagnosis of liver diseases in pati...

Open access Research Article 10.9734/jammr/2025/v37i105958

Hepatitis B Vaccine Awareness and Uptake: Insights from a World Hepatitis Day Community Survey in Rivers State, Nigeria

Sarah Abere, Boma Oyan & Samuel Asonye · Asian Journal of Medicine and Health · 2025

Background: Hepatitis B (HBV) poses a continual Public Health threat globally despite the availability of a safe, and effective vaccine. The HBV vaccine provides a 98-100% immunity thereby preventing complications of the infection such as liver cirrhosis. Despite the wide coverag...

Open access Research Article 10.9734/ajmah/2025/v23i21178

Blood Pressure Control and Its Determinants Among Outpatient Hypertensive Subjects in Port Harcourt: A Survey of Two Teaching Hospitals

Boma Oyan, Sarah Abere, Ernest O Nwazor, Aisha O Ajala, Florence K Briggs & Linda Iroegbu-Emeruem · Journal of Advances in Medical and Pharmaceutical Sciences · 2024

Background: Elevated blood pressure (BP) is associated with increased cardiovascular disease mortality and all-cause mortality. Despite availability of medication for treatment of hypertension and prevention of complications, the goal of universal optimal BP control has remained...

Open access Research Article 10.9734/jamps/2024/v26i4679

Catastrophic Health Expenditure and Impoverishment Amongst Hepatitis B Patients in a Resource-Poor Setting

Aloni Alali, Benjamin Osaro, Ishmael Jaja, Sarah Abere & Akinwumi Fajola · Asian Journal of Medicine and Health · 2024

Introduction: The economic burden of managing hepatitis B has become a concern because viral hepatitis disease is a global public health problem that resulted in more deaths in 2016 than HIV and AIDs, Tuberculosis and Malaria individually. This study aimed at estimating the catas...

Open access Research Article 10.9734/ajmah/2024/v22i2980